Country: Germany
Language: English
Source: HMA (Heads of Medicines Agencies)
pentobarbital 300 mg/ml
WdT - Wirtschaftsgenossenschaft Deutscher Tierärzte eG
QN51AA01
Solution for injection
pentobarbital
[ ALL ], Cats, Cattle, Chicken, Dogs, Horses, Other Birds, Pigs, Rabbit
2008-04-30
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Release 300mg/ml, solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances: Pentobarbital sodium 300 mg/ml For a full list of excipients see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection A clear, colourless to light yellow solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Horses, ponies, cattle, swine, dogs, cats, minks, polecats, hares, rabbits, guinea pigs, hamsters, rats, mice, chicken, pigeons, birds, snakes, tortoises, lizards, frogs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For euthanasia in animals. 4.3 CONTRAINDICATIONS Do not use in animals intended for human or animal consumption. Do not use for anaesthetic purposes. Do not use for intracoelomic injection in chelonia as the time to death may be unnecessarily prolonged compared with intravenous administration. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Carcases of animals euthanised with this product should be disposed of in accordance with national legislation. Carcases of animals euthanised with this product should not be fed to other animals due to the risk of secondary intoxication. The intraperitoneal route of administration may cause a prolonged onset of action with an increased risk of adverse effects noted in 4.6. Prior sedation is advisable. The intrapulmonary route of administration may cause a prolonged onset of action with an increased risk of adverse effects noted in 4.6 and should be reserved for cases where other routes of administration Read the complete document